Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Understanding when it’s too late to start retirement planning is crucial for your financial health. Take action to secure your future now.
19,461 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
In a fresh market view, an online analyst tells holders tune toward price structure rather than headlines. The chart ...
Goldman Sachs sets COIN target at $235, signaling renewed confidence in Coinbase as crypto markets stabilize and inst...
Bitcoin struggles to clear the $90K barrier as four market forces converge. Analysts say a sustained weekly close abo...
XRP eased lower toward a critical support level as sellers held sway, signaling thinning upside momentum for the near...
XRP trades near a 15-week low around $1.30 as ETF demand remains steady while on-chain withdrawals intensify, signali...
A New York congressional race has become a proxy fight over AI regulation as tech backers pour millions into ads oppo...
Micron Technology has unleashed a dramatic first half, but the market now eyes a cautious microns stock price predict...
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
A value-factor ETF has surged past the S&P 500 through February 2026, signaling a shift toward fundamentals amid vola...
Bitcoin’s inter-exchange flow metric flashed a golden cross, prompting talk of a multi-week rally. Analysts say the p...
Geopolitical tensions and stubborn inflation are rattling markets. Even higher-income americans turning cautious sign...